Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017)

D Łażewska, K Kieć-Kononowicz - Expert opinion on therapeutic …, 2018 - Taylor & Francis
Introduction: Since years, ligands blocking histamine H3 receptor (H3R) activity
(antagonists/inverse agonists) are interesting targets in the search for new cures for CNS …

Recent advances in histamine H3 receptor antagonists/inverse agonists

D Łażewska, K Kieć-Kononowicz - Expert Opinion on Therapeutic …, 2010 - Taylor & Francis
Importance of the field: Histamine H3 receptor (H3R) antagonists/inverse agonists can be
therapeutically useful in the treatment of various CNS, metabolic syndrome and allergic …

New developments around histamine H3 receptor antagonists/inverse agonists: a patent review (2010 – present)

D Łażewska, K Kieć-Kononowicz - Expert Opinion on Therapeutic …, 2014 - Taylor & Francis
Introduction: Histamine H3 receptor (H3R) is involved in the central and peripheral
regulation of levels of histamine and other neurotransmitters (eg, acetylcholine …

Several down, a few to go: histamine H3 receptor ligands making the final push towards the market?

S Kuhne, M Wijtmans, HD Lim, R Leurs… - Expert opinion on …, 2011 - Taylor & Francis
Introduction: The histamine H3 receptor (H3R) plays a pivotal role in a plethora of
therapeutic areas. Blocking the H3R with antagonists/inverse agonists has been postulated …

Histamine H3 receptor ligands break ground in a remarkable plethora of therapeutic areas

M Wijtmans, R Leurs, I Esch - Expert opinion on investigational …, 2007 - Taylor & Francis
The neurotransmitter histamine exerts its action through four distinct histamine receptors.
The histamine H1 and H2 receptor are well established drug targets, whereas the histamine …

The evolution of histamine H3 antagonists/inverse agonists

EP Lebois, CK Jones… - Current topics in medicinal …, 2011 - ingentaconnect.com
This article describes our efforts along with recent advances in the development, biological
evaluation and clinical proof of concept of small molecule histamine H3 antagonists/inverse …

[HTML][HTML] Multiple Targeting Approaches on Histamine H3 Receptor Antagonists

MA Khanfar, A Affini, K Lutsenko, K Nikolic… - Frontiers in …, 2016 - frontiersin.org
With the very recent market approval of pitolisant (Wakix®), the interest in clinical
applications of novel multifunctional histamine H3 receptor antagonists has clearly …

Recent advances in the development of histamine H3 antagonists

M Berlin, CW Boyce - Expert Opinion on Therapeutic Patents, 2007 - Taylor & Francis
The histamine H3 receptor is involved in the central and peripheral regulation of levels of
histamine and other neurotransmitters (eg, acetylcholine, noradrenaline, dopamine …

Histamine H3 receptor antagonists/inverse agonists: Where do they go?

N Ghamari, O Zarei, JA Arias-Montaño, D Reiner… - Pharmacology & …, 2019 - Elsevier
Since the discovery of the histamine H 3 receptor in 1983, tremendous advances in the
pharmacological aspects of H 3 receptor antagonists/inverse agonists have been …

The histamine H3 receptor as a therapeutic drug target for CNS disorders

MJ Gemkow, AJ Davenport, S Harich, BA Ellenbroek… - Drug discovery today, 2009 - Elsevier
The histamine H3 receptor plays a regulatory role in the pre-synaptic release of histamine
and other neurotransmitters, making it an attractive target for CNS indications including …